期刊文献+

五灵丸、五味子丸和联苯双酯治疗慢性乙型肝炎的疗效比较 被引量:11

Therapeutic comparisons of wulingwan, schisandra fruit and biphenyl dimethyl dicarboxylale for chronic hapatitis B
下载PDF
导出
摘要 作者比较了五灵丸、五味子丸和联苯双酯治疗慢性乙型肝炎的疗效.结果五灵丸对乏力、纳差的显效率显著高于五味子丸(93.8%,84.3%对40.0%,30.0%,P<0.05);对体征的改善五灵丸组治后的无效例次(4例次)明显少于另两组的14例次.实验检测示五灵丸降S-GPT,S-GOT至正常的百分率显著高于五味子丸组(90.6%,87.5%对36.6%,23.5%,P<0.05);在降S-GOT方面五灵丸还优于联苯双酯(87.5%对26.3%P<0.05).对于血清白蛋白五灵丸治后与治前比有显著提高(t=2.57,P<0.05),而另药无此差异.对黄疸指数的消退五灵丸也优于联苯双酯(t=2.67,P<0.05).提示五灵丸治疗慢性肝炎优于五味子丸和联苯双酯. Efficiency among Wulirtgwan (WW ), Schisandra fruit (SF ) and biphcnyl dimethyl dicarboxylate (BDD ) for treating chrome hepatitis B (CHB ) was compared and studied in the report . The study consisted of 92 CHB discs who were divided randomly into three groups and treated with WW , SF and BDD , respectively . It was found that WW was more effective than SF and BDD in improving symptoms , especially hypodynamia and anorexia . After treatment, there were 4 out of 32 patients whose abnormal physical signs such as enlargement of liver did not improve in WW group , while in the other two groups there were 14 out of 30 cases remained the unchanged abnormal signs cither . The percentage of abnormal serum GPT and GOT restoring to normal level in WW group (90.6% and 87.6%) were higher than that in SF group (36.6% and 23.5%) and in BDD group (66.6% and 26.3% ). Serum albumin rose obviously after treatment in WW group , while this kind of change was not observed in the other two groups . The results above suggest that WW is more effective than SF and BDD in treatment of CHB.
出处 《第四军医大学学报》 1991年第6期436-439,共4页 Journal of the Fourth Military Medical University
关键词 中成药 联苯双酯 乙型肝炎 疗效 ready - made patent drugs biphenyl dimethyl dicarboxylalc chronic persist hepatitis chronic active hepatitis
  • 相关文献

参考文献3

  • 1杨卫东,朱鸿良,赵保路.丹参的氧自由基清除作用[J].中国药理学通报,1990,6(2):118-121. 被引量:333
  • 2阎荣,周永兴,刘俊彬.五灵丹丸治疗慢性肝炎的临床观察[J]第四军医大学学报,1987(06).
  • 3周永兴,阎荣,缪京莉.五灵丹丸与五味子丸对慢性肝炎疗效的比较[J]第四军医大学学报,1987(06).

共引文献332

同被引文献161

引证文献11

二级引证文献113

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部